Updated information on COVID-19 and Flu: Restricted visitation is now in effect
Category
Cancer
Sub Category
Bladder, Genitourinary GU
Study Name
S1602 : A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-Naïve High-Grade Non-Muscle Invasive Bladder Cancer
Principal Investigator
Gordan Srkalovic
Study Information
https://clinicaltrials.gov/ct2/show/NCT03091660?term=S1602&draw=2&rank=1
Contact for Questions
Tracy, RN 517.364.2835

Site view: at a glance